Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BioNTech SE has announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore.
read more
OncoTEX Inc and Sterling Pharma Solutions announced the signing of a clinical development agreement for the manufacture of OncoTex’s novel platinum-resistant oncology drug candidate, OxaliTEX.
read more
LaunchWorks announced that it has increased its filling capacity for the production of diagnostic test kits with the addition of new automation equipment at its Beverly, MA and Anjou, Canada facilities.
read more
Richter-Helm BioLogics GmbH & Co. KG has announced the start of construction for an expansion project at its cGMP manufacturing facility in Bovenau, Germany.
read more
Catalent has acquired Promethera’s cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA, including its 32,400 square-foot facility in Gosselies, Belgium.
read more
Sterling Pharma Solutions, has announced that its customer, ADC Therapeutics SA, has received FDA approval for the antibody drug conjugate ZYNLONTATM that its Deeside facility contributed to developing.
read more
AGC Biologics has announced its partnership with Oculis to manufacture OCS-02, a Phase II investigational drug targeting both Dry Eye Disease and Anterior Uveitis, at its Heidelberg facility.
read more
LabConnect and Cryoport have announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics.
read more
Lonza has announced significant investments to expand its mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US).
read more
Vectura and Inspira Pharmaceuticals have announced an agreement to develop an inhaled formulation of Inspira’s lead drug candidate for the potential treatment of COVID-19.
read more
Integrated drug discovery and pre-clinical solutions provider, Sygnature Discovery, has appointed Dr. David Lustig to the role of Vice President Business Development - United States.
read more
Deloitte has announced its acquisition of Iperion Life Sciences Consultancy.
read more
Elligo Health Research has announced its partnership with N. Harris Computer Corporation through its Sidus Insights, Inc. subsidiary.
read more
Clean Biologics has announced the acquisition of Biodextris Inc, a Contract Development and Manufacturing Organization (CDMO) based in Laval (Montreal), Canada.
read more
CN Bio announced that the FDA has extended their research collaboration, for a further three years.
read more